Literature DB >> 22544323

ZFP36 expression impairs glioblastoma cell lines viability and invasiveness by targeting multiple signal transduction pathways.

Tommaso Selmi1, Andrea Martello, Tatiana Vignudelli, Erika Ferrari, Alexis Grande, Claudia Gemelli, Paolo Salomoni, Sergio Ferrari, Tommaso Zanocco-Marani.   

Abstract

RNA binding proteins belonging to the TIS11/TTP gene family regulate the stability of multiple targets. Their inactivation or deregulated expression has recently been related to cancer, and it has been suggested that they are capable of displaying tumor suppressor activities. Here we describe three new targets of ZFP36 (PIM-1, PIM-3 and XIAP) and show by different approaches that its ectopic expression is capable of impairing glioblastoma cell lines viability and invasiveness by interfering with different transduction pathways. Moreover, we provide evidence that compounds capable of inducing the expression of TIS11/TTP genes determine a comparable biological effect on the same cell contexts.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22544323     DOI: 10.4161/cc.20309

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  16 in total

1.  Cell of origin determines clinically relevant subtypes of MLL-rearranged AML.

Authors:  A V Krivtsov; M E Figueroa; A U Sinha; M C Stubbs; Z Feng; P J M Valk; R Delwel; K Döhner; L Bullinger; A L Kung; A M Melnick; S A Armstrong
Journal:  Leukemia       Date:  2012-12-13       Impact factor: 11.528

2.  Tristetraprolin inhibits the growth of human glioma cells through downregulation of urokinase plasminogen activator/urokinase plasminogen activator receptor mRNAs.

Authors:  Jinhyun Ryu; Nal Ae Yoon; Yeon Kyung Lee; Joo Yeon Jeong; Seokmin Kang; Hyemin Seong; Jungil Choi; Nammi Park; Nayoung Kim; Wha Ja Cho; Sun Ha Paek; Gyeong Jae Cho; Wan Sung Choi; Jae-Yong Park; Jeong Woo Park; Sang Soo Kang
Journal:  Mol Cells       Date:  2014-12-30       Impact factor: 5.034

3.  Multicellular biomarkers of drug resistance as promising targets for glioma precision medicine and predictors of patient survival.

Authors:  Yuting Lu; Yongzhao Shao
Journal:  Cancer Drug Resist       Date:  2022-06-02

Review 4.  Steering tumor progression through the transcriptional response to growth factors and stroma.

Authors:  Morris E Feldman; Yosef Yarden
Journal:  FEBS Lett       Date:  2014-05-27       Impact factor: 4.124

Review 5.  Systematic review of protein biomarkers of invasive behavior in glioblastoma.

Authors:  Eli T Sayegh; Gurvinder Kaur; Orin Bloch; Andrew T Parsa
Journal:  Mol Neurobiol       Date:  2013-11-24       Impact factor: 5.590

Review 6.  RNA binding proteins as regulators of immune cell biology.

Authors:  R Newman; J McHugh; M Turner
Journal:  Clin Exp Immunol       Date:  2015-09-11       Impact factor: 4.330

7.  ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly.

Authors:  Tommaso Selmi; Claudia Alecci; Miriam dell' Aquila; Lucia Montorsi; Andrea Martello; Filippo Guizzetti; Nicola Volpi; Sandra Parenti; Sergio Ferrari; Paolo Salomoni; Alexis Grande; Tommaso Zanocco-Marani
Journal:  BMC Cancer       Date:  2015-05-06       Impact factor: 4.430

8.  MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.

Authors:  Fei Liu; Shimeng Zhang; Zhen Zhao; Xinru Mao; Jinlan Huang; Zixian Wu; Lei Zheng; Qian Wang
Journal:  Oncotarget       Date:  2016-04-12

9.  Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer.

Authors:  Zi-Ran Wei; Chao Liang; Dan Feng; Ya-Jun Cheng; Wei-Min Wang; De-Jun Yang; Yue-Xiang Wang; Qing-Ping Cai
Journal:  Oncotarget       Date:  2016-04-05

10.  Interaction with Pyruvate Kinase M2 Destabilizes Tristetraprolin by Proteasome Degradation and Regulates Cell Proliferation in Breast Cancer.

Authors:  Liangqian Huang; Zhenhai Yu; Zhenchao Zhang; Wenjing Ma; Shaoli Song; Gang Huang
Journal:  Sci Rep       Date:  2016-03-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.